Morning Research: Eli Lilly & Co., Bristol-Myers Squibb Co., Allergan Inc.,
and Endo Health Solutions Inc.
LONDON, November 4, 2013
LONDON, November 4, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market edged higher on Friday, November 01, 2013. The S&P 500
ended the day at 1,761.64, up 0.29%; the Dow Jones Industrial Average closed
at 15,615.55, up 0.45%; and the NASDAQ Composite finished at 3,922.04, up
0.06%. Shares in the healthcare-drug makers sector ended on a mixed note, even
as the broader market posted gains. The major movers in the industry included
Eli Lilly & Company (NYSE: LLY), Bristol-Myers Squibb Company (NYSE: BMY),
Allergan Inc. (NYSE: AGN), and Endo Health Solutions Inc. (NASDAQ: ENDP).
AAAResearchReports.com has released full comprehensive research on LLY, BMY,
AGN, and ENDP. These free technical analyses can be downloaded by signing up
Eli Lilly & Co.'s stock advanced on Friday, as the broader market posted
gains. The company's shares closed the day 1.12% higher at $50.38, after
trading between $49.81 and $50.43. A total of 5.05 million shares were traded,
which is below the daily average volume of 5.69 million. The company's shares
have gained 0.36% in the previous three trading sessions, outperforming the
S&P 500, which has fallen by 0.58% during the same period. However, Eli Lilly
& Co.'s stock is trading below its 50-day and 200-day moving averages of
$51.00 and $53.17, respectively. Download free report on LLY upon registration
On Friday, shares in Bristol-Myers Squibb Co. edged lower to close at $52.48,
down 0.08% from the previous day's closing price of $52.52. The company's
shares vacillated between $52.36 and $53.20 during the trading session. A
total of 7.33 million shares were traded, which is above the daily average
volume of 6.97 million. Despite Friday's losses, the company's shares have
gained 11.83% in the last one month and 19.71% in the previous three months,
outperforming the S&P 500, which has advanced 4.21% and 3.04% during the
respective periods. Furthermore, Bristol-Myers Squibb Co.'s stock is trading
near its 52-week high of $53.68 and above its 50-day and 200-day moving
averages of $46.44 and $42.80, respectively. BMY technical report can be
accessed for free by signing up at:
Allergan Inc.'s stock fell by 0.13% on Friday, even as the broader market
posted gains. The company's shares closed the day at $90.49, after trading
between $90.02 and $91.17. A total of 2.28 million shares were traded, which
is above the daily average volume of 1.91 million. Despite Friday's pullback,
the company's stock has gained 0.10% in the last one month, compared to gain
of 4.21% in the S&P 500 during the same period. However, the company's shares
are trading above their 50-day moving average of $90.18. The free report on
AGN can be downloaded by signing up now at:
On Friday, shares in Endo Health Solutions Inc. advanced to close the day at
$44.22, up 1.12% from the previous day's closing price of $43.73. The
company's shares vacillated between $43.69 and $44.38 during the trading
session. A total of 1.29 million shares were traded, which is below the daily
average volume of 1.72 million. The company's shares have gained 12.78% in the
previous three months, outperforming the S&P 500, which has gained 3.04%
during the same period. Additionally, Endo Health Solutions Inc.'s stock is
trading above its 50-day and 200-day moving averages of $44.11 and $36.97,
respectively. A free report on ENDP can be accessed by registering at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: Phone #: + 1 (646) 396-9126, Contact Name: Peter F. Jones, Email ID:
Press spacebar to pause and continue. Press esc to stop.